Paschen Steffen, Natera-Villalba Elena, Pineda-Pardo José A, Del Álamo Marta, Rodríguez-Rojas Rafael, Hensler Johannes, Deuschl Günther, Obeso Jose A, Helmers Ann-Kristin, Martínez-Fernández Raúl
Department of Neurology, University Hospital Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany.
Centro Integral de Neurociencias AC (CINAC), HM Universitario Puerta del Sur, Madrid, Spain.
Mov Disord. 2025 May;40(5):823-833. doi: 10.1002/mds.30159. Epub 2025 Mar 3.
Unilateral focused ultrasound ventral intermediate thalamotomy (Vim-FUS) is effective in treating Parkinson's disease (PD) tremor. Ultrasound ablation of the subthalamic nucleus (STN-FUS) has demonstrated efficacy in improving all cardinal motor features of PD, including tremor.
To compare the efficacy in parkinsonian tremor control between Vim-FUS and STN-FUS.
Retrospective, two-center study including consecutive PD patients with medication-refractory tremor who underwent unilateral Vim-FUS or STN-FUS between June 2015 and August 2022. Patients scored ≥2 for postural and/or resting tremor on the most affected body side in the off-medication state. The primary outcome was the between-group difference in tremor improvement on the treated side at 12-month follow-up, including a responder's analysis. Data regarding safety, global motor status, and dopaminergic requirements were also collected. Group comparisons used repeated measures ANOVA with Bonferroni correction; statistical significance for P < 0.05.
Among 175 patients treated at the two sites, 63 were included (23 Vim-FUS, 40 STN-FUS). At baseline, both groups were equivalent in disease duration (6.7 ± 3.8 vs. 6.1 ± 3.4 years, P = 0.48) and tremor severity (5.7 ± 1.5 vs. 5.9 ± 2.5, P = 0.7). While the benefit in tremor was equivalent between the groups at 4 months (P = 0.15), tremor reduction was greater in STN- FUS patients at 12 months (4.4 ± 2.0, 95% CI 3.7-5.0 compared with 2.7 ± 3.7, 95% CI 1.1-4.3 for Vim-FUS, P = 0.012). In 47.5% (19/40) of STN-FUS patients tremor was completely abolished versus 8.7% (2/23) in Vim-FUS patients (P < 0.01). Most adverse events were mild (91%) and resolved by 12 months.
STN-FUS and Vim-FUS significantly improved medication-refractory PD tremor; however, subthalamotomy might have greater and more sustained effect. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
单侧聚焦超声丘脑腹中间核切开术(Vim-FUS)在治疗帕金森病(PD)震颤方面有效。丘脑底核超声消融术(STN-FUS)已证明在改善PD的所有主要运动特征(包括震颤)方面具有疗效。
比较Vim-FUS和STN-FUS在控制帕金森病震颤方面的疗效。
一项回顾性、双中心研究,纳入2015年6月至2022年8月期间接受单侧Vim-FUS或STN-FUS治疗的药物难治性震颤的连续性PD患者。患者在停药状态下,最受影响身体侧的姿势性和/或静止性震颤评分≥2分。主要结局是12个月随访时治疗侧震颤改善的组间差异,包括反应者分析。还收集了有关安全性、整体运动状态和多巴胺能需求的数据。组间比较采用重复测量方差分析并进行Bonferroni校正;P<0.05具有统计学意义。
在两个中心治疗的175例患者中,63例被纳入研究(23例接受Vim-FUS,40例接受STN-FUS)。基线时,两组在病程(6.7±3.8年 vs. 6.1±3.4年,P = 0.48)和震颤严重程度(5.7±1.5 vs. 5.9±2.5,P = 0.7)方面相当。虽然两组在4个月时震颤改善情况相当(P = 0.15),但STN-FUS组患者在12个月时震颤减轻更明显(4.4±2.0,95%CI 3.7 - 5.0,而Vim-FUS组为2.7±3.7,95%CI 1.1 - 4.3,P = 0.012)。47.5%(19/40)的STN-FUS患者震颤完全消失,而Vim-FUS患者中这一比例为8.7%(2/23)(P<0.01)。大多数不良事件为轻度(91%),并在12个月时缓解。
STN-FUS和Vim-FUS均能显著改善药物难治性PD震颤;然而,丘脑底核切开术可能具有更大且更持久的效果。© 2025作者。《运动障碍》由Wiley Periodicals LLC代表国际帕金森和运动障碍协会出版。